Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Vascular Pharmacology|September 25, 2025
PCSK9: Its Role in Lipid Metabolism and as a Novel Target for the Treatment of Metabolic Kidney DiseaseHongqian Li, Ling Qi, Dongmei Zhang, et al.
Frontiers in Neuroscience|December 23, 2017
Abstinent Heroin Addicts Tend to Take Risks: ERP and Source LocalizationQinglin Zhao, Hongqian Li, Bin Hu, et al.
Frontiers in Human Neuroscience|February 8, 2018
Neural Correlates of Drug-Related Attentional Bias in Heroin DependenceQinglin Zhao, Hongqian Li, Bin Hu, et al.
Sichuan Da Xue Xue Bao. Yi Xue Ban = Journal of Sichuan University. Medical Science Edition|March 20, 2025
[Nafamostat Mesylate Alleviates Renal Ischemia-Reperfusion Injury in a Rat Model Through HMGB1 Modulation: An Omics Analysis -Based Study of the Protective Effect and the Mechanisms Involved]Yuxuan Wu, Hongqian Li, Linfeng Liu, et al.
Sichuan Da Xue Xue Bao. Yi Xue Ban = Journal of Sichuan University. Medical Science Edition|March 16, 2026
[Study of the Protective Effect and Mechanism of Inclisiran on Renal Tissue in a Type 2 Diabetes Mouse Model via the Transforming Growth Factor-β Pathway]Hongqian Li, Bo Chen, Xin Xiang, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|December 23, 2025
Nafamostat Mesylate Protects Against Acute Renal Ischemia-Reperfusion Injury by Alleviating Mitochondrial Dysfunction, Inhibiting Ferroptosis, and Regulating Proximal Tubular Cells: A Multi-Omics AnalysisYu Wang, Yuxuan Wu, Hongqian Li, et al.
Pageof 1